4basebio UK Societas stock forecast
4basebio UK Societas (88Q) Stock Forecast & Price Target
88Q Analyst Ratings
88Q Stock 12 Month Forecast
Average Price Target
€11.98▲(104.76% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Charles Weston | RBC Capital | €11.98 | buy | 104.76%Upside | Reiterated | 09/28/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Charles WestonRBC Capital | BuyReiterated€11.98 | 09/28/26 | 104.76%Upside |
Best Analysts Covering 4basebio UK Societas
Copying Charles Weston's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -11.80% per trade.
Copying Charles Weston's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -28.42% per trade.
Copying Charles Weston's trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -28.20% per trade.
88Q Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 1 | 1 |
In the current month, 88Q has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 88Q average Analyst price target in the past 3 months is 11.98.
88Q Financial Forecast
88Q Earnings Forecast
Next quarter’s earnings estimate for 88Q is -EUR 0.70 with a range of -EUR 0.70 to -EUR 0.70. The previous quarter’s EPS was -EUR 0.67. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
88Q Sales Forecast
Next quarter’s sales forecast for 88Q is EUR 916.38K with a range of EUR 916.38K to EUR 916.38K. The previous quarter’s sales results were EUR 304.68K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

